

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 8.36865624 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.50998084 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 7.50998084 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.21541975 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 7.21541975 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.74050161 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.72995778 |
| 8 | epoxygenase P450 pathway (GO:0019373) | 6.57164797 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 6.05627210 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 6.05627210 |
| 11 | tryptophan catabolic process (GO:0006569) | 6.05627210 |
| 12 | omega-hydroxylase P450 pathway (GO:0097267) | 6.00039000 |
| 13 | kynurenine metabolic process (GO:0070189) | 5.92121074 |
| 14 | glyoxylate metabolic process (GO:0046487) | 5.86909456 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.86728251 |
| 16 | high-density lipoprotein particle remodeling (GO:0034375) | 5.85468590 |
| 17 | tryptophan metabolic process (GO:0006568) | 5.70998731 |
| 18 | urea metabolic process (GO:0019627) | 5.67366947 |
| 19 | urea cycle (GO:0000050) | 5.67366947 |
| 20 | negative regulation of fibrinolysis (GO:0051918) | 5.63804606 |
| 21 | alpha-linolenic acid metabolic process (GO:0036109) | 5.51946693 |
| 22 | oxidative demethylation (GO:0070989) | 5.49996620 |
| 23 | drug metabolic process (GO:0017144) | 5.46897176 |
| 24 | regulation of fibrinolysis (GO:0051917) | 5.43157621 |
| 25 | cysteine metabolic process (GO:0006534) | 5.36537914 |
| 26 | sulfur amino acid catabolic process (GO:0000098) | 5.34528857 |
| 27 | protein carboxylation (GO:0018214) | 5.31461101 |
| 28 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.31461101 |
| 29 | nitrogen cycle metabolic process (GO:0071941) | 5.21785056 |
| 30 | regulation of protein activation cascade (GO:2000257) | 5.19581887 |
| 31 | regulation of cholesterol esterification (GO:0010872) | 5.19413135 |
| 32 | regulation of triglyceride catabolic process (GO:0010896) | 5.19045517 |
| 33 | complement activation, alternative pathway (GO:0006957) | 5.17651249 |
| 34 | reverse cholesterol transport (GO:0043691) | 5.16152521 |
| 35 | serine family amino acid catabolic process (GO:0009071) | 5.07372220 |
| 36 | bile acid metabolic process (GO:0008206) | 5.00870248 |
| 37 | plasma lipoprotein particle remodeling (GO:0034369) | 5.00261954 |
| 38 | protein-lipid complex remodeling (GO:0034368) | 5.00261954 |
| 39 | macromolecular complex remodeling (GO:0034367) | 5.00261954 |
| 40 | intestinal cholesterol absorption (GO:0030299) | 4.99122162 |
| 41 | phospholipid efflux (GO:0033700) | 4.95128237 |
| 42 | aromatic amino acid family metabolic process (GO:0009072) | 4.90511316 |
| 43 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.87334708 |
| 44 | regulation of complement activation (GO:0030449) | 4.83019018 |
| 45 | triglyceride homeostasis (GO:0070328) | 4.75421873 |
| 46 | acylglycerol homeostasis (GO:0055090) | 4.75421873 |
| 47 | negative regulation of cholesterol transport (GO:0032375) | 4.74421531 |
| 48 | negative regulation of sterol transport (GO:0032372) | 4.74421531 |
| 49 | tyrosine metabolic process (GO:0006570) | 4.74305959 |
| 50 | S-adenosylmethionine metabolic process (GO:0046500) | 4.72070357 |
| 51 | homocysteine metabolic process (GO:0050667) | 4.67717418 |
| 52 | phenylpropanoid metabolic process (GO:0009698) | 4.67680693 |
| 53 | plasma lipoprotein particle clearance (GO:0034381) | 4.57031615 |
| 54 | alpha-amino acid catabolic process (GO:1901606) | 4.56665807 |
| 55 | cellular ketone body metabolic process (GO:0046950) | 4.55730970 |
| 56 | amino-acid betaine metabolic process (GO:0006577) | 4.50868813 |
| 57 | lysine catabolic process (GO:0006554) | 4.48452273 |
| 58 | lysine metabolic process (GO:0006553) | 4.48452273 |
| 59 | regulation of plasminogen activation (GO:0010755) | 4.45540156 |
| 60 | cholesterol efflux (GO:0033344) | 4.44426717 |
| 61 | glycine metabolic process (GO:0006544) | 4.43367225 |
| 62 | coenzyme catabolic process (GO:0009109) | 4.36274304 |
| 63 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.36212215 |
| 64 | bile acid and bile salt transport (GO:0015721) | 4.34291652 |
| 65 | alkaloid metabolic process (GO:0009820) | 4.30084899 |
| 66 | indolalkylamine metabolic process (GO:0006586) | 4.30076992 |
| 67 | plasma lipoprotein particle assembly (GO:0034377) | 4.29373198 |
| 68 | imidazole-containing compound metabolic process (GO:0052803) | 4.29119653 |
| 69 | cellular glucuronidation (GO:0052695) | 4.23688265 |
| 70 | cellular amino acid catabolic process (GO:0009063) | 4.20842451 |
| 71 | amine catabolic process (GO:0009310) | 4.20745225 |
| 72 | cellular biogenic amine catabolic process (GO:0042402) | 4.20745225 |
| 73 | glutamate metabolic process (GO:0006536) | 4.19845880 |
| 74 | regulation of lipoprotein particle clearance (GO:0010984) | 4.17504191 |
| 75 | serine family amino acid metabolic process (GO:0009069) | 4.16409990 |
| 76 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.14975053 |
| 77 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.14975053 |
| 78 | heme transport (GO:0015886) | 4.14838144 |
| 79 | serine family amino acid biosynthetic process (GO:0009070) | 4.08982227 |
| 80 | aldehyde catabolic process (GO:0046185) | 4.08726879 |
| 81 | negative regulation of blood coagulation (GO:0030195) | 4.08698410 |
| 82 | negative regulation of hemostasis (GO:1900047) | 4.08698410 |
| 83 | benzene-containing compound metabolic process (GO:0042537) | 4.06775896 |
| 84 | low-density lipoprotein particle remodeling (GO:0034374) | 4.06360426 |
| 85 | arginine metabolic process (GO:0006525) | 4.05464538 |
| 86 | cellular modified amino acid catabolic process (GO:0042219) | 4.03213142 |
| 87 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.02531858 |
| 88 | ethanol oxidation (GO:0006069) | 4.01742915 |
| 89 | fibrinolysis (GO:0042730) | 3.98031367 |
| 90 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.96302791 |
| 91 | ketone body metabolic process (GO:1902224) | 3.94585101 |
| 92 | drug catabolic process (GO:0042737) | 3.92694702 |
| 93 | positive regulation of lipid catabolic process (GO:0050996) | 3.88286336 |
| 94 | ethanol metabolic process (GO:0006067) | 3.86908058 |
| 95 | protein-lipid complex assembly (GO:0065005) | 3.85441624 |
| 96 | blood coagulation, intrinsic pathway (GO:0007597) | 3.84947066 |
| 97 | cholesterol homeostasis (GO:0042632) | 3.84385648 |
| 98 | plasma lipoprotein particle organization (GO:0071827) | 3.82675280 |
| 99 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.81565375 |
| 100 | negative regulation of lipase activity (GO:0060192) | 3.81414268 |
| 101 | sterol homeostasis (GO:0055092) | 3.77924769 |
| 102 | uronic acid metabolic process (GO:0006063) | 3.76102280 |
| 103 | glucuronate metabolic process (GO:0019585) | 3.76102280 |
| 104 | cofactor catabolic process (GO:0051187) | 3.75807847 |
| 105 | phospholipid homeostasis (GO:0055091) | 3.74961132 |
| 106 | negative regulation of coagulation (GO:0050819) | 3.71111394 |
| 107 | carboxylic acid catabolic process (GO:0046395) | 3.69875859 |
| 108 | organic acid catabolic process (GO:0016054) | 3.69875859 |
| 109 | complement activation, classical pathway (GO:0006958) | 3.68347166 |
| 110 | protein activation cascade (GO:0072376) | 3.65472753 |
| 111 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.64586862 |
| 112 | regulation of bile acid biosynthetic process (GO:0070857) | 3.64225724 |
| 113 | complement activation (GO:0006956) | 3.63240221 |
| 114 | flavonoid metabolic process (GO:0009812) | 3.62175024 |
| 115 | negative regulation of wound healing (GO:0061045) | 3.61599751 |
| 116 | drug transmembrane transport (GO:0006855) | 3.61471316 |
| 117 | cytolysis (GO:0019835) | 3.61345458 |
| 118 | short-chain fatty acid metabolic process (GO:0046459) | 3.61285594 |
| 119 | protein-lipid complex subunit organization (GO:0071825) | 3.60179393 |
| 120 | lipoprotein metabolic process (GO:0042157) | 3.59984674 |
| 121 | acetyl-CoA metabolic process (GO:0006084) | 3.59389732 |
| 122 | cholesterol transport (GO:0030301) | 3.53933981 |
| 123 | sterol transport (GO:0015918) | 3.53933981 |
| 124 | negative regulation of protein activation cascade (GO:2000258) | 3.51543722 |
| 125 | polyketide metabolic process (GO:0030638) | 3.49911938 |
| 126 | doxorubicin metabolic process (GO:0044598) | 3.49911938 |
| 127 | daunorubicin metabolic process (GO:0044597) | 3.49911938 |
| 128 | acute-phase response (GO:0006953) | 3.48714630 |
| 129 | L-methionine salvage (GO:0071267) | 3.48470619 |
| 130 | L-methionine biosynthetic process (GO:0071265) | 3.48470619 |
| 131 | amino acid salvage (GO:0043102) | 3.48470619 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.38082686 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.23499149 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.07832679 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.48281019 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.20630011 |
| 6 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.07475753 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.89435686 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.01521197 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.97433421 |
| 10 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.22468551 |
| 11 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.17831224 |
| 12 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.04336598 |
| 13 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9882225 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.96311600 |
| 15 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.59413967 |
| 16 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.58817936 |
| 17 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.51621144 |
| 18 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.48730460 |
| 19 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.43210637 |
| 20 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.42649908 |
| 21 | GATA1_22025678_ChIP-Seq_K562_Human | 1.40330705 |
| 22 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.32448176 |
| 23 | VDR_22108803_ChIP-Seq_LS180_Human | 1.30966442 |
| 24 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.30490390 |
| 25 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.28602952 |
| 26 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.27353219 |
| 27 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.25874576 |
| 28 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.21361793 |
| 29 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.21052606 |
| 30 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.19113486 |
| 31 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.17279314 |
| 32 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.16036905 |
| 33 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.15008164 |
| 34 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.14255731 |
| 35 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.08848829 |
| 36 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.08768687 |
| 37 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.07897805 |
| 38 | * GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.06438054 |
| 39 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.05724080 |
| 40 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.05050876 |
| 41 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.04930918 |
| 42 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.04930918 |
| 43 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.04209737 |
| 44 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.03267148 |
| 45 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.03267148 |
| 46 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.03169604 |
| 47 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.02240908 |
| 48 | * TCF4_22108803_ChIP-Seq_LS180_Human | 1.00538697 |
| 49 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.00227576 |
| 50 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98701678 |
| 51 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.98268820 |
| 52 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.97875732 |
| 53 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.95037986 |
| 54 | STAT3_23295773_ChIP-Seq_U87_Human | 0.95003669 |
| 55 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.93707261 |
| 56 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.93105606 |
| 57 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.92850157 |
| 58 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.92850157 |
| 59 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.91157587 |
| 60 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.90436945 |
| 61 | TCF4_23295773_ChIP-Seq_U87_Human | 0.89807507 |
| 62 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.89080506 |
| 63 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.88720099 |
| 64 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.88576722 |
| 65 | * GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.86731108 |
| 66 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.86285857 |
| 67 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.85766357 |
| 68 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.84720889 |
| 69 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.84258396 |
| 70 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.84167440 |
| 71 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.84009473 |
| 72 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.83536117 |
| 73 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.83395754 |
| 74 | TP53_16413492_ChIP-PET_HCT116_Human | 0.82936202 |
| 75 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.82872243 |
| 76 | ERA_21632823_ChIP-Seq_H3396_Human | 0.82803506 |
| 77 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.82500388 |
| 78 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.82109930 |
| 79 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.82073298 |
| 80 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.82029106 |
| 81 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.81746225 |
| 82 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.81279721 |
| 83 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.78747921 |
| 84 | GATA3_26560356_Chip-Seq_TH1_Human | 0.78602576 |
| 85 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.78597025 |
| 86 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.78466811 |
| 87 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.78018663 |
| 88 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.77410691 |
| 89 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.76634325 |
| 90 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.76476109 |
| 91 | NFYA_21822215_ChIP-Seq_K562_Human | 0.76178389 |
| 92 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.75997192 |
| 93 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.74766522 |
| 94 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.74553945 |
| 95 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.73835266 |
| 96 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.73087364 |
| 97 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.72732078 |
| 98 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.72686724 |
| 99 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.70053128 |
| 100 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.68196579 |
| 101 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.66952063 |
| 102 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.65733694 |
| 103 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.65593069 |
| 104 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.65156817 |
| 105 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.64792145 |
| 106 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.64602844 |
| 107 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.64214867 |
| 108 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.64168117 |
| 109 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.64168117 |
| 110 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.64012180 |
| 111 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63781175 |
| 112 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.61454698 |
| 113 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.59185019 |
| 114 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57824779 |
| 115 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.57215514 |
| 116 | AR_20517297_ChIP-Seq_VCAP_Human | 0.56536964 |
| 117 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.55091244 |
| 118 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.54494325 |
| 119 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.54031365 |
| 120 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.52632359 |
| 121 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.52481739 |
| 122 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.51728133 |
| 123 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.51591624 |
| 124 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.51000236 |
| 125 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.49960602 |
| 126 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49562344 |
| 127 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.49242980 |
| 128 | CBP_21632823_ChIP-Seq_H3396_Human | 0.49026738 |
| 129 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.48514883 |
| 130 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.46881986 |
| 131 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46744515 |
| 132 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.45927622 |
| 133 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.44930046 |
| 134 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.44917548 |
| 135 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.44751969 |
| 136 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.44335076 |
| 137 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.42808216 |
| 138 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.42572319 |
| 139 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.42354532 |
| 140 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.42271896 |
| 141 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.41873747 |
| 142 | GATA1_19941826_ChIP-Seq_K562_Human | 0.41134803 |
| 143 | GATA2_19941826_ChIP-Seq_K562_Human | 0.40447232 |
| 144 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.40426504 |
| 145 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.38021929 |
| 146 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.37366106 |
| 147 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.37272746 |
| 148 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.37168642 |
| 149 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.36191590 |
| 150 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.35543414 |
| 151 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.35012062 |
| 152 | NCOR_22424771_ChIP-Seq_293T_Human | 0.34931775 |
| 153 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.34628399 |
| 154 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.34529269 |
| 155 | * CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.34277145 |
| 156 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.33959376 |
| 157 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.33890784 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.32489098 |
| 2 | MP0005360_urolithiasis | 7.78033780 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.36192459 |
| 4 | MP0005365_abnormal_bile_salt | 6.10342068 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.02222568 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.34349296 |
| 7 | MP0003252_abnormal_bile_duct | 3.92478817 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.66883969 |
| 9 | MP0009840_abnormal_foam_cell | 3.49766288 |
| 10 | MP0005083_abnormal_biliary_tract | 2.96526724 |
| 11 | MP0001666_abnormal_nutrient_absorption | 2.76278107 |
| 12 | MP0003195_calcinosis | 2.75519600 |
| 13 | MP0005332_abnormal_amino_acid | 2.72928150 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.34218430 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.14652815 |
| 16 | MP0000609_abnormal_liver_physiology | 2.14560743 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.09270054 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 1.88675797 |
| 19 | MP0003868_abnormal_feces_composition | 1.87249894 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.80912010 |
| 21 | MP0009697_abnormal_copulation | 1.77641890 |
| 22 | MP0001764_abnormal_homeostasis | 1.70903807 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.57285177 |
| 24 | MP0005451_abnormal_body_composition | 1.46227971 |
| 25 | MP0003011_delayed_dark_adaptation | 1.37732653 |
| 26 | MP0003656_abnormal_erythrocyte_physiolo | 1.28247019 |
| 27 | MP0003186_abnormal_redox_activity | 1.24921450 |
| 28 | MP0009643_abnormal_urine_homeostasis | 1.23523534 |
| 29 | MP0001986_abnormal_taste_sensitivity | 1.16133780 |
| 30 | MP0000598_abnormal_liver_morphology | 1.14833538 |
| 31 | MP0003705_abnormal_hypodermis_morpholog | 1.13529469 |
| 32 | MP0000604_amyloidosis | 1.11485199 |
| 33 | MP0005647_abnormal_sex_gland | 1.08459541 |
| 34 | MP0009764_decreased_sensitivity_to | 1.04258547 |
| 35 | MP0002254_reproductive_system_inflammat | 1.00932560 |
| 36 | MP0009763_increased_sensitivity_to | 0.99704047 |
| 37 | MP0010368_abnormal_lymphatic_system | 0.97139864 |
| 38 | MP0005636_abnormal_mineral_homeostasis | 0.93708220 |
| 39 | MP0005551_abnormal_eye_electrophysiolog | 0.90429381 |
| 40 | MP0008469_abnormal_protein_level | 0.88491754 |
| 41 | MP0009642_abnormal_blood_homeostasis | 0.87649099 |
| 42 | MP0004147_increased_porphyrin_level | 0.86699716 |
| 43 | MP0005408_hypopigmentation | 0.85211210 |
| 44 | MP0005084_abnormal_gallbladder_morpholo | 0.82229561 |
| 45 | MP0006036_abnormal_mitochondrial_physio | 0.81617417 |
| 46 | MP0005376_homeostasis/metabolism_phenot | 0.81385751 |
| 47 | MP0002876_abnormal_thyroid_physiology | 0.78886363 |
| 48 | MP0009765_abnormal_xenobiotic_induced | 0.78175464 |
| 49 | MP0004043_abnormal_pH_regulation | 0.77110004 |
| 50 | MP0002078_abnormal_glucose_homeostasis | 0.76898254 |
| 51 | MP0009053_abnormal_anal_canal | 0.67917831 |
| 52 | MP0002971_abnormal_brown_adipose | 0.67868133 |
| 53 | MP0005220_abnormal_exocrine_pancreas | 0.67627971 |
| 54 | MP0005334_abnormal_fat_pad | 0.67456918 |
| 55 | MP0005266_abnormal_metabolism | 0.66476438 |
| 56 | MP0005535_abnormal_body_temperature | 0.66449072 |
| 57 | MP0003690_abnormal_glial_cell | 0.62993700 |
| 58 | MP0004142_abnormal_muscle_tone | 0.60695284 |
| 59 | MP0004130_abnormal_muscle_cell | 0.60271729 |
| 60 | MP0005670_abnormal_white_adipose | 0.60068974 |
| 61 | MP0003879_abnormal_hair_cell | 0.59667329 |
| 62 | MP0000639_abnormal_adrenal_gland | 0.59533484 |
| 63 | MP0003646_muscle_fatigue | 0.59012696 |
| 64 | MP0003329_amyloid_beta_deposits | 0.58995676 |
| 65 | MP0005448_abnormal_energy_balance | 0.58954690 |
| 66 | MP0002160_abnormal_reproductive_system | 0.58553564 |
| 67 | MP0001756_abnormal_urination | 0.57985938 |
| 68 | MP0002822_catalepsy | 0.57030175 |
| 69 | MP0001661_extended_life_span | 0.56262387 |
| 70 | MP0003890_abnormal_embryonic-extraembry | 0.55168622 |
| 71 | MP0006035_abnormal_mitochondrial_morpho | 0.53211940 |
| 72 | MP0003136_yellow_coat_color | 0.52531941 |
| 73 | MP0005464_abnormal_platelet_physiology | 0.52159280 |
| 74 | MP0005646_abnormal_pituitary_gland | 0.51443627 |
| 75 | MP0003718_maternal_effect | 0.50937006 |
| 76 | MP0005377_hearing/vestibular/ear_phenot | 0.49812576 |
| 77 | MP0003878_abnormal_ear_physiology | 0.49812576 |
| 78 | MP0005645_abnormal_hypothalamus_physiol | 0.49715512 |
| 79 | MP0001324_abnormal_eye_pigmentation | 0.48962378 |
| 80 | MP0005395_other_phenotype | 0.48175369 |
| 81 | MP0003183_abnormal_peptide_metabolism | 0.47859796 |
| 82 | MP0001915_intracranial_hemorrhage | 0.46502259 |
| 83 | MP0003638_abnormal_response/metabolism_ | 0.45364109 |
| 84 | MP0002136_abnormal_kidney_physiology | 0.45148257 |
| 85 | MP0005389_reproductive_system_phenotype | 0.44556030 |
| 86 | MP0008873_increased_physiological_sensi | 0.44432784 |
| 87 | MP0008874_decreased_physiological_sensi | 0.44022435 |
| 88 | MP0004782_abnormal_surfactant_physiolog | 0.43833698 |
| 89 | MP0001485_abnormal_pinna_reflex | 0.43415930 |
| 90 | MP0005166_decreased_susceptibility_to | 0.42459274 |
| 91 | MP0008872_abnormal_physiological_respon | 0.42436041 |
| 92 | MP0003436_decreased_susceptibility_to | 0.41710504 |
| 93 | MP0002837_dystrophic_cardiac_calcinosis | 0.41500243 |
| 94 | MP0003075_altered_response_to | 0.41246916 |
| 95 | MP0003953_abnormal_hormone_level | 0.41178615 |
| 96 | MP0002928_abnormal_bile_duct | 0.40707221 |
| 97 | MP0003724_increased_susceptibility_to | 0.40334284 |
| 98 | MP0004381_abnormal_hair_follicle | 0.40292429 |
| 99 | MP0005187_abnormal_penis_morphology | 0.39606046 |
| 100 | MP0009780_abnormal_chondrocyte_physiolo | 0.38803777 |
| 101 | MP0001919_abnormal_reproductive_system | 0.38112879 |
| 102 | MP0002909_abnormal_adrenal_gland | 0.37838259 |
| 103 | MP0005248_abnormal_Harderian_gland | 0.37316123 |
| 104 | MP0002796_impaired_skin_barrier | 0.37094890 |
| 105 | MP0000372_irregular_coat_pigmentation | 0.37088998 |
| 106 | MP0006082_CNS_inflammation | 0.36221471 |
| 107 | MP0002638_abnormal_pupillary_reflex | 0.34492656 |
| 108 | MP0008877_abnormal_DNA_methylation | 0.34289171 |
| 109 | MP0000249_abnormal_blood_vessel | 0.33468401 |
| 110 | MP0002132_abnormal_respiratory_system | 0.33349534 |
| 111 | MP0004924_abnormal_behavior | 0.32786788 |
| 112 | MP0005386_behavior/neurological_phenoty | 0.32786788 |
| 113 | MP0009115_abnormal_fat_cell | 0.32550653 |
| 114 | MP0005409_darkened_coat_color | 0.32510289 |
| 115 | MP0000230_abnormal_systemic_arterial | 0.32392876 |
| 116 | MP0005666_abnormal_adipose_tissue | 0.32340162 |
| 117 | MP0000579_abnormal_nail_morphology | 0.32193375 |
| 118 | MP0005410_abnormal_fertilization | 0.32053169 |
| 119 | MP0004883_abnormal_blood_vessel | 0.31785408 |
| 120 | MP0000371_diluted_coat_color | 0.31696290 |
| 121 | MP0009672_abnormal_birth_weight | 0.31423716 |
| 122 | MP0001929_abnormal_gametogenesis | 0.30719667 |
| 123 | MP0001243_abnormal_dermal_layer | 0.30505682 |
| 124 | MP0003632_abnormal_nervous_system | 0.30437760 |
| 125 | MP0000427_abnormal_hair_cycle | 0.30399509 |
| 126 | MP0001845_abnormal_inflammatory_respons | 0.29732401 |
| 127 | MP0002282_abnormal_trachea_morphology | 0.29358499 |
| 128 | MP0009384_cardiac_valve_regurgitation | 0.28163139 |
| 129 | MP0001881_abnormal_mammary_gland | 0.27898850 |
| 130 | MP0002970_abnormal_white_adipose | 0.27181221 |
| 131 | MP0001944_abnormal_pancreas_morphology | 0.26283518 |
| 132 | MP0003699_abnormal_female_reproductive | 0.26102593 |
| 133 | MP0002168_other_aberrant_phenotype | 0.25935148 |
| 134 | MP0005164_abnormal_response_to | 0.24879899 |
| 135 | MP0001853_heart_inflammation | 0.23983833 |
| 136 | MP0004264_abnormal_extraembryonic_tissu | 0.22828362 |
| 137 | MP0005167_abnormal_blood-brain_barrier | 0.22570920 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.39301930 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.35578748 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.24566061 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 6.74002891 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.58469384 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.53696589 |
| 7 | Xanthomatosis (HP:0000991) | 6.32070340 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.61866121 |
| 9 | Complement deficiency (HP:0004431) | 5.18409014 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.96887081 |
| 11 | Joint hemorrhage (HP:0005261) | 4.81425177 |
| 12 | Hyperammonemia (HP:0001987) | 4.60879095 |
| 13 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.50712443 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 4.45861362 |
| 15 | Epidermoid cyst (HP:0200040) | 4.42095641 |
| 16 | Hyperglycinemia (HP:0002154) | 4.39049110 |
| 17 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.26576151 |
| 18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.23984277 |
| 19 | Hypoalphalipoproteinemia (HP:0003233) | 4.23073455 |
| 20 | Ketosis (HP:0001946) | 4.20863529 |
| 21 | Fat malabsorption (HP:0002630) | 4.19133587 |
| 22 | Abnormality of methionine metabolism (HP:0010901) | 4.18377781 |
| 23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.11984543 |
| 24 | Hyperglycinuria (HP:0003108) | 4.00400854 |
| 25 | Hypoglycemic coma (HP:0001325) | 3.99220092 |
| 26 | Abnormality of glycine metabolism (HP:0010895) | 3.94621048 |
| 27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.94621048 |
| 28 | Abnormality of the intrinsic pathway (HP:0010989) | 3.80398194 |
| 29 | Abnormality of complement system (HP:0005339) | 3.79777237 |
| 30 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.76937121 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.66170262 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.56227119 |
| 33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.40497053 |
| 34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.39580656 |
| 35 | Hyperbilirubinemia (HP:0002904) | 3.33394731 |
| 36 | Steatorrhea (HP:0002570) | 3.11062971 |
| 37 | Spontaneous abortion (HP:0005268) | 3.08741920 |
| 38 | Abnormality of serum amino acid levels (HP:0003112) | 3.05036603 |
| 39 | Delayed CNS myelination (HP:0002188) | 3.03921912 |
| 40 | Abnormality of nucleobase metabolism (HP:0010932) | 3.03093464 |
| 41 | Ketoacidosis (HP:0001993) | 3.02889151 |
| 42 | Hypochromic microcytic anemia (HP:0004840) | 2.98035178 |
| 43 | Hepatocellular carcinoma (HP:0001402) | 2.94810805 |
| 44 | Myocardial infarction (HP:0001658) | 2.86663920 |
| 45 | Metabolic acidosis (HP:0001942) | 2.83110945 |
| 46 | Osteomalacia (HP:0002749) | 2.74000656 |
| 47 | Acanthocytosis (HP:0001927) | 2.71234987 |
| 48 | Skin nodule (HP:0200036) | 2.71010117 |
| 49 | Systemic lupus erythematosus (HP:0002725) | 2.67694083 |
| 50 | Dicarboxylic aciduria (HP:0003215) | 2.67157407 |
| 51 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.67157407 |
| 52 | Abnormality of purine metabolism (HP:0004352) | 2.66171636 |
| 53 | Nephritis (HP:0000123) | 2.61309824 |
| 54 | Lethargy (HP:0001254) | 2.61033398 |
| 55 | Hyperphosphaturia (HP:0003109) | 2.59285767 |
| 56 | Vascular calcification (HP:0004934) | 2.54391788 |
| 57 | Hypoglycemic seizures (HP:0002173) | 2.52617294 |
| 58 | Malnutrition (HP:0004395) | 2.47392659 |
| 59 | Abnormal gallbladder morphology (HP:0012437) | 2.44187348 |
| 60 | Spastic diplegia (HP:0001264) | 2.41027337 |
| 61 | Cerebral edema (HP:0002181) | 2.40747225 |
| 62 | Cholelithiasis (HP:0001081) | 2.38912252 |
| 63 | Amyloidosis (HP:0011034) | 2.38015352 |
| 64 | Gout (HP:0001997) | 2.35240925 |
| 65 | Mitral stenosis (HP:0001718) | 2.33904949 |
| 66 | Glomerulonephritis (HP:0000099) | 2.32834292 |
| 67 | Irritability (HP:0000737) | 2.32736518 |
| 68 | Cholecystitis (HP:0001082) | 2.32350995 |
| 69 | Abnormal gallbladder physiology (HP:0012438) | 2.32350995 |
| 70 | Fair hair (HP:0002286) | 2.32097154 |
| 71 | Neonatal onset (HP:0003623) | 2.30116996 |
| 72 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.30018564 |
| 73 | Abnormal urine phosphate concentration (HP:0012599) | 2.25727682 |
| 74 | Cardiovascular calcification (HP:0011915) | 2.25586613 |
| 75 | Gingival bleeding (HP:0000225) | 2.21682429 |
| 76 | Pancreatitis (HP:0001733) | 2.18197616 |
| 77 | Sensorimotor neuropathy (HP:0007141) | 2.16209370 |
| 78 | Menorrhagia (HP:0000132) | 2.15226012 |
| 79 | Esophageal varix (HP:0002040) | 2.14548165 |
| 80 | Generalized aminoaciduria (HP:0002909) | 2.12361993 |
| 81 | Vomiting (HP:0002013) | 2.09416801 |
| 82 | Brushfield spots (HP:0001088) | 2.09049806 |
| 83 | Poikilocytosis (HP:0004447) | 2.08175797 |
| 84 | Late onset (HP:0003584) | 2.08107231 |
| 85 | Thrombophlebitis (HP:0004418) | 2.07706266 |
| 86 | Arthropathy (HP:0003040) | 2.05896896 |
| 87 | Enlarged kidneys (HP:0000105) | 2.05268171 |
| 88 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.02980162 |
| 89 | Reduced antithrombin III activity (HP:0001976) | 2.02904450 |
| 90 | Hydroxyprolinuria (HP:0003080) | 1.99695790 |
| 91 | Abnormality of proline metabolism (HP:0010907) | 1.99695790 |
| 92 | Opisthotonus (HP:0002179) | 1.98658172 |
| 93 | Abnormality of the gallbladder (HP:0005264) | 1.98554407 |
| 94 | Hemorrhage of the eye (HP:0011885) | 1.96689905 |
| 95 | Abnormal cartilage morphology (HP:0002763) | 1.95622523 |
| 96 | Abnormality of iron homeostasis (HP:0011031) | 1.93710443 |
| 97 | Renal cortical cysts (HP:0000803) | 1.93125553 |
| 98 | Rickets (HP:0002748) | 1.92746179 |
| 99 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.91818674 |
| 100 | Chronic hepatic failure (HP:0100626) | 1.88561148 |
| 101 | Hypophosphatemic rickets (HP:0004912) | 1.83604097 |
| 102 | Abnormality of alanine metabolism (HP:0010916) | 1.82684654 |
| 103 | Hyperalaninemia (HP:0003348) | 1.82684654 |
| 104 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.82684654 |
| 105 | Retinal atrophy (HP:0001105) | 1.82581930 |
| 106 | Pigmentary retinal degeneration (HP:0001146) | 1.82516113 |
| 107 | Elevated hepatic transaminases (HP:0002910) | 1.80308717 |
| 108 | Abnormality of vitamin metabolism (HP:0100508) | 1.79266175 |
| 109 | Alkalosis (HP:0001948) | 1.78816410 |
| 110 | Increased serum pyruvate (HP:0003542) | 1.77080675 |
| 111 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.76386994 |
| 112 | Proximal tubulopathy (HP:0000114) | 1.75447989 |
| 113 | Abnormality of urine glucose concentration (HP:0011016) | 1.74680651 |
| 114 | Glycosuria (HP:0003076) | 1.74680651 |
| 115 | Bifid scrotum (HP:0000048) | 1.73945701 |
| 116 | Nausea (HP:0002018) | 1.73793528 |
| 117 | Abnormal tarsal ossification (HP:0008369) | 1.73035590 |
| 118 | Pulmonary embolism (HP:0002204) | 1.70743390 |
| 119 | Megaloblastic anemia (HP:0001889) | 1.69126329 |
| 120 | Abnormal biliary tract physiology (HP:0012439) | 1.67269545 |
| 121 | Bile duct proliferation (HP:0001408) | 1.67269545 |
| 122 | Hypothermia (HP:0002045) | 1.64569874 |
| 123 | Abnormality of vitamin B metabolism (HP:0004340) | 1.57233581 |
| 124 | Vaginal fistula (HP:0004320) | 1.55907661 |
| 125 | Thyroiditis (HP:0100646) | 1.55745161 |
| 126 | Elevated alkaline phosphatase (HP:0003155) | 1.54155263 |
| 127 | Joint swelling (HP:0001386) | 1.52105961 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.23016784 |
| 2 | FGFR4 | 4.57254644 |
| 3 | ERN1 | 4.45583756 |
| 4 | SIK1 | 4.44317969 |
| 5 | ACVR1B | 4.14413200 |
| 6 | MUSK | 3.08145987 |
| 7 | PDK2 | 3.02010926 |
| 8 | TAOK3 | 3.00459920 |
| 9 | STK39 | 2.98480088 |
| 10 | EIF2AK3 | 2.91939283 |
| 11 | INSRR | 2.83321006 |
| 12 | ERBB4 | 2.78776899 |
| 13 | OXSR1 | 2.66373751 |
| 14 | MST1R | 2.36633430 |
| 15 | WNK3 | 2.28993960 |
| 16 | PKN2 | 2.28772190 |
| 17 | MAP2K4 | 2.17509122 |
| 18 | WNK4 | 2.12616344 |
| 19 | MAP3K12 | 2.11924589 |
| 20 | NLK | 2.02690628 |
| 21 | FLT3 | 1.95106189 |
| 22 | BMPR1B | 1.88885308 |
| 23 | MAPK11 | 1.88781790 |
| 24 | PIK3CG | 1.82343349 |
| 25 | TYK2 | 1.77943643 |
| 26 | DAPK2 | 1.76543746 |
| 27 | CASK | 1.72288019 |
| 28 | FRK | 1.69224421 |
| 29 | BRSK2 | 1.66454091 |
| 30 | PAK3 | 1.66099060 |
| 31 | LATS1 | 1.61312137 |
| 32 | TRIB3 | 1.58723830 |
| 33 | ABL2 | 1.54762189 |
| 34 | PTK6 | 1.54167841 |
| 35 | NEK9 | 1.37698852 |
| 36 | GRK6 | 1.32679048 |
| 37 | NTRK3 | 1.29955006 |
| 38 | KDR | 1.28645178 |
| 39 | FGFR2 | 1.23804900 |
| 40 | PIK3CA | 1.22957166 |
| 41 | MST4 | 1.21825348 |
| 42 | JAK2 | 1.20763085 |
| 43 | MAP3K7 | 1.18853316 |
| 44 | TBK1 | 1.13463513 |
| 45 | MAP4K2 | 1.11842750 |
| 46 | MAP3K4 | 1.11471306 |
| 47 | PRKAA2 | 1.08872465 |
| 48 | MAP2K3 | 1.06400293 |
| 49 | PINK1 | 1.05692605 |
| 50 | ERBB2 | 1.02622368 |
| 51 | ADRBK2 | 1.01183259 |
| 52 | MAP3K10 | 1.00924193 |
| 53 | MAP3K3 | 0.98224551 |
| 54 | MAP3K14 | 0.97666071 |
| 55 | MAPK4 | 0.94440989 |
| 56 | JAK1 | 0.94361426 |
| 57 | MKNK2 | 0.94316629 |
| 58 | MAP3K11 | 0.94093131 |
| 59 | MAPK15 | 0.93235682 |
| 60 | ZAK | 0.92862136 |
| 61 | FER | 0.91594415 |
| 62 | PRKCZ | 0.90032547 |
| 63 | MET | 0.89919523 |
| 64 | TNIK | 0.88316047 |
| 65 | TLK1 | 0.84776522 |
| 66 | EPHA3 | 0.82654677 |
| 67 | RIPK1 | 0.80941002 |
| 68 | MAP2K6 | 0.80736851 |
| 69 | EPHB1 | 0.80622295 |
| 70 | CDK6 | 0.79265256 |
| 71 | PRKACG | 0.78663375 |
| 72 | STK38L | 0.78402151 |
| 73 | PRKCE | 0.77715052 |
| 74 | STK16 | 0.75514139 |
| 75 | PNCK | 0.75430086 |
| 76 | PRKCI | 0.74640945 |
| 77 | SGK1 | 0.74442950 |
| 78 | CAMK2G | 0.74155223 |
| 79 | TIE1 | 0.72876798 |
| 80 | MAPK12 | 0.71667279 |
| 81 | DYRK1B | 0.70373718 |
| 82 | IRAK3 | 0.69193447 |
| 83 | CSK | 0.67901238 |
| 84 | CAMKK2 | 0.67668369 |
| 85 | NUAK1 | 0.66832609 |
| 86 | PRKAA1 | 0.64399227 |
| 87 | GSK3A | 0.64312545 |
| 88 | RPS6KB1 | 0.64096852 |
| 89 | PBK | 0.63248900 |
| 90 | CSNK1D | 0.62963093 |
| 91 | MAPK13 | 0.62402633 |
| 92 | TESK2 | 0.60644818 |
| 93 | PTK2 | 0.57963695 |
| 94 | IKBKE | 0.56798509 |
| 95 | SGK3 | 0.55870480 |
| 96 | TAOK2 | 0.54882723 |
| 97 | CAMK1D | 0.54617034 |
| 98 | FGFR1 | 0.54499142 |
| 99 | BRD4 | 0.54210346 |
| 100 | PRKACA | 0.53591882 |
| 101 | PDPK1 | 0.52309712 |
| 102 | PRKCQ | 0.52159716 |
| 103 | GRK1 | 0.52011406 |
| 104 | TGFBR2 | 0.51060222 |
| 105 | WNK1 | 0.49265744 |
| 106 | NEK1 | 0.48803351 |
| 107 | CSF1R | 0.48405761 |
| 108 | MAPK7 | 0.47870626 |
| 109 | CSNK1G1 | 0.47835625 |
| 110 | PRKG1 | 0.47624587 |
| 111 | FGFR3 | 0.47115012 |
| 112 | MAP2K1 | 0.45030838 |
| 113 | PRKACB | 0.42531360 |
| 114 | EPHA4 | 0.41828568 |
| 115 | IGF1R | 0.40928851 |
| 116 | CDK19 | 0.40785880 |
| 117 | CDK4 | 0.39335151 |
| 118 | MAP3K5 | 0.39271999 |
| 119 | PRKCG | 0.38882142 |
| 120 | ADRBK1 | 0.37963975 |
| 121 | RET | 0.37914691 |
| 122 | MAP2K2 | 0.37912960 |
| 123 | CSNK1A1 | 0.36600351 |
| 124 | BMPR2 | 0.36373748 |
| 125 | PLK2 | 0.36222988 |
| 126 | SGK2 | 0.36156232 |
| 127 | MAPKAPK3 | 0.36015661 |
| 128 | DYRK1A | 0.35554235 |
| 129 | MAP3K13 | 0.35059915 |
| 130 | CSNK1E | 0.34397147 |
| 131 | EPHB2 | 0.32600425 |
| 132 | ICK | 0.32247294 |
| 133 | PDK1 | 0.32034707 |
| 134 | CAMK4 | 0.31958974 |
| 135 | OBSCN | 0.31431574 |
| 136 | EGFR | 0.31066318 |
| 137 | CSNK1G3 | 0.30203334 |
| 138 | TNK2 | 0.29697146 |
| 139 | PRKCA | 0.29526714 |
| 140 | CSNK1G2 | 0.29414587 |
| 141 | PHKG1 | 0.29361696 |
| 142 | PHKG2 | 0.29361696 |
| 143 | PKN1 | 0.28702680 |
| 144 | MAP3K1 | 0.28565088 |
| 145 | CSNK2A1 | 0.28459307 |
| 146 | MTOR | 0.28443437 |
| 147 | PRKG2 | 0.27783966 |
| 148 | BMX | 0.26566598 |
| 149 | MAP3K2 | 0.26374547 |
| 150 | SGK494 | 0.25789530 |
| 151 | SGK223 | 0.25789530 |
| 152 | AKT3 | 0.24882942 |
| 153 | CSNK1A1L | 0.24301778 |
| 154 | MAP3K6 | 0.23486443 |
| 155 | ABL1 | 0.21411271 |
| 156 | LATS2 | 0.18338922 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.49448006 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.47763125 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.34949193 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.26964849 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.05987671 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.73601064 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.68238439 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.66423352 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.65809454 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.52754483 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.49277569 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.37640799 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.23138577 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.15559805 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.15493311 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.09478490 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.98088903 |
| 18 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.95947888 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.92190097 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.91151172 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.89474897 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.88448383 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.80481310 |
| 24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.77835870 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.77310690 |
| 26 | Retinol metabolism_Homo sapiens_hsa00830 | 1.70954042 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.70013116 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.69940686 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.68843160 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.68083791 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.63108931 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.55548304 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.53708107 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.50718508 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.50129751 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.49290940 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.43697706 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.42301830 |
| 39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.38430236 |
| 40 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.37247448 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.35727143 |
| 42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.35528549 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.32354446 |
| 44 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.28985414 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.18056329 |
| 46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.17300287 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.15311671 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.13866943 |
| 49 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.03730151 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.02602914 |
| 51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.02336474 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98997610 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.97786002 |
| 54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.97270156 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.96900832 |
| 56 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.92392590 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.91497401 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.83906179 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.79346628 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.78577364 |
| 61 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.71207070 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70730085 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68682904 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60075067 |
| 65 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.59125778 |
| 66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52820779 |
| 67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.47705894 |
| 68 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47334896 |
| 69 | Prion diseases_Homo sapiens_hsa05020 | 0.36020689 |
| 70 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35880454 |
| 71 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.29522489 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.29042707 |
| 73 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.25264060 |
| 74 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.20369285 |
| 75 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.19848191 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.19678327 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.17502497 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17486528 |
| 79 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.17145327 |
| 80 | Circadian rhythm_Homo sapiens_hsa04710 | 0.06017284 |
| 81 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.05544302 |
| 82 | Pertussis_Homo sapiens_hsa05133 | 0.03515621 |
| 83 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.2408822 |
| 84 | Bladder cancer_Homo sapiens_hsa05219 | -0.2260377 |
| 85 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2109370 |
| 86 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.2102747 |
| 87 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2084091 |
| 88 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1916001 |
| 89 | Mineral absorption_Homo sapiens_hsa04978 | -0.1905630 |
| 90 | Hepatitis C_Homo sapiens_hsa05160 | -0.1800828 |
| 91 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1778682 |
| 92 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1772105 |
| 93 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.1562732 |
| 94 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1514471 |
| 95 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1469900 |
| 96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1459727 |
| 97 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1322403 |
| 98 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1291324 |
| 99 | Phototransduction_Homo sapiens_hsa04744 | -0.1290168 |
| 100 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1264306 |
| 101 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1156251 |
| 102 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0819246 |
| 103 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0585101 |
| 104 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.0528973 |
| 105 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0492866 |
| 106 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0231324 |
| 107 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0209455 |
| 108 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0190026 |
| 109 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0062588 |

